Gene therapy is ultra-ultraexpensive. How it could be made cheaper

Managed Healthcare Executive August 18, 2024
Don Sapatkin

The key to lowering gene therapy costs – and getting treatments to where they are most needed – could be making them in middle- low-income countries, argue the authors of a recent commentary in Nature.

Here’s something you may not have heard about gene therapy, the emerging and very costly field of medicine in which doctors bioengineer a gene and release it into the body to essentially replace a faulty original that is causing a genetic disease: The cost is,in fact, so great that four approved gene therapies have already been withdrawn from the market because so few people or healthcare systems can afford them.

The authors of a commentary published July 17 in Nature wonder whether the same thing...

Today's Sponsors

Today's Sponsor